Click for best price
Endothelin Antagonists Therapeutics Market Size, Share 2024
The global Endothelin Antagonists Therapeutics market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Endothelin Antagonists Therapeutics include Gilead Sciences, Inc, Sun Pharmaceutical Industries Ltd, Lupin, Zydus Group, Endo International plc, Mylan NV, Teva Pharmaceutical Industries Ltd, Sigmapharm Laboratories , LLC and Alembic Pharmaceuticals Limited, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Endothelin are the type of therapeutics that inhibits the action of endothelin and is thus effective for treating pulmonary arterial hypertension. This receptor, which plays a major role in regulating vascular tone, is found between the lumen and underlying media of the pulmonary vasculature. For patients suffering from the pulmonary hypertension, the body secrete high amount of endothelin that causes the blood vessels to be constricted and increase in the BP in the pulmonary arteries.
This report aims to provide a comprehensive presentation of the global market for Endothelin Antagonists Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endothelin Antagonists Therapeutics. This report contains market size and forecasts of Endothelin Antagonists Therapeutics in global, including the following market information:
Global Endothelin Antagonists Therapeutics Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Endothelin Antagonists Therapeutics Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Endothelin Antagonists Therapeutics companies in 2023 (%)
We surveyed the Endothelin Antagonists Therapeutics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endothelin Antagonists Therapeutics Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Endothelin Antagonists Therapeutics Market Segment Percentages, by Type, 2023 (%)
Oral
Parenteral
Global Endothelin Antagonists Therapeutics Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Endothelin Antagonists Therapeutics Market Segment Percentages, by Application, 2023 (%)
Cardiovascular Diseases
Scleroderma
Other
Global Endothelin Antagonists Therapeutics Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Endothelin Antagonists Therapeutics Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endothelin Antagonists Therapeutics revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Endothelin Antagonists Therapeutics revenues share in global market, 2023 (%)
Key companies Endothelin Antagonists Therapeutics sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Endothelin Antagonists Therapeutics sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences, Inc
Sun Pharmaceutical Industries Ltd
Lupin
Zydus Group
Endo International plc
Mylan NV
Teva Pharmaceutical Industries Ltd
Sigmapharm Laboratories , LLC
Alembic Pharmaceuticals Limited
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals LLC
AstraZeneca
Johnsons & Johnsons Private limited
GSK Plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Endothelin Antagonists Therapeutics, market overview.
Chapter 2: Global Endothelin Antagonists Therapeutics market size in revenue and volume.
Chapter 3: Detailed analysis of Endothelin Antagonists Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Endothelin Antagonists Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Endothelin Antagonists Therapeutics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Endothelin Antagonists Therapeutics Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Endothelin Antagonists Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Endothelin Antagonists Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Endothelin Antagonists Therapeutics Overall Market Size
2.1 Global Endothelin Antagonists Therapeutics Market Size: 2023 VS 2030
2.2 Global Endothelin Antagonists Therapeutics Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Endothelin Antagonists Therapeutics Sales: 2019-2030
3 Company Landscape
3.1 Top Endothelin Antagonists Therapeutics Players in Global Market
3.2 Top Global Endothelin Antagonists Therapeutics Companies Ranked by Revenue
3.3 Global Endothelin Antagonists Therapeutics Revenue by Companies
3.4 Global Endothelin Antagonists Therapeutics Sales by Companies
3.5 Global Endothelin Antagonists Therapeutics Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Endothelin Antagonists Therapeutics Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Endothelin Antagonists Therapeutics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Endothelin Antagonists Therapeutics Players in Global Market
3.8.1 List of Global Tier 1 Endothelin Antagonists Therapeutics Companies
3.8.2 List of Global Tier 2 and Tier 3 Endothelin Antagonists Therapeutics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Endothelin Antagonists Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Oral
4.1.3 Parenteral
4.2 By Type - Global Endothelin Antagonists Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Endothelin Antagonists Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Endothelin Antagonists Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
4.3 By Type - Global Endothelin Antagonists Therapeutics Sales & Forecasts
4.3.1 By Type - Global Endothelin Antagonists Therapeutics Sales, 2019-2024
4.3.2 By Type - Global Endothelin Antagonists Therapeutics Sales, 2025-2030
4.3.3 By Type - Global Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
4.4 By Type - Global Endothelin Antagonists Therapeutics Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Endothelin Antagonists Therapeutics Market Size, 2023 & 2030
5.1.2 Cardiovascular Diseases
5.1.3 Scleroderma
5.1.4 Other
5.2 By Application - Global Endothelin Antagonists Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Endothelin Antagonists Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Endothelin Antagonists Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
5.3 By Application - Global Endothelin Antagonists Therapeutics Sales & Forecasts
5.3.1 By Application - Global Endothelin Antagonists Therapeutics Sales, 2019-2024
5.3.2 By Application - Global Endothelin Antagonists Therapeutics Sales, 2025-2030
5.3.3 By Application - Global Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
5.4 By Application - Global Endothelin Antagonists Therapeutics Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Endothelin Antagonists Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Endothelin Antagonists Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Endothelin Antagonists Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Endothelin Antagonists Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
6.3 By Region - Global Endothelin Antagonists Therapeutics Sales & Forecasts
6.3.1 By Region - Global Endothelin Antagonists Therapeutics Sales, 2019-2024
6.3.2 By Region - Global Endothelin Antagonists Therapeutics Sales, 2025-2030
6.3.3 By Region - Global Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Endothelin Antagonists Therapeutics Revenue, 2019-2030
6.4.2 By Country - North America Endothelin Antagonists Therapeutics Sales, 2019-2030
6.4.3 US Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.4.4 Canada Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.4.5 Mexico Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Endothelin Antagonists Therapeutics Revenue, 2019-2030
6.5.2 By Country - Europe Endothelin Antagonists Therapeutics Sales, 2019-2030
6.5.3 Germany Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.4 France Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.5 U.K. Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.6 Italy Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.7 Russia Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.8 Nordic Countries Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.5.9 Benelux Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Endothelin Antagonists Therapeutics Revenue, 2019-2030
6.6.2 By Region - Asia Endothelin Antagonists Therapeutics Sales, 2019-2030
6.6.3 China Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.6.4 Japan Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.6.5 South Korea Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.6.6 Southeast Asia Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.6.7 India Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Endothelin Antagonists Therapeutics Revenue, 2019-2030
6.7.2 By Country - South America Endothelin Antagonists Therapeutics Sales, 2019-2030
6.7.3 Brazil Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.7.4 Argentina Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Endothelin Antagonists Therapeutics Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Endothelin Antagonists Therapeutics Sales, 2019-2030
6.8.3 Turkey Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.8.4 Israel Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.8.5 Saudi Arabia Endothelin Antagonists Therapeutics Market Size, 2019-2030
6.8.6 UAE Endothelin Antagonists Therapeutics Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Gilead Sciences, Inc
7.1.1 Gilead Sciences, Inc Company Summary
7.1.2 Gilead Sciences, Inc Business Overview
7.1.3 Gilead Sciences, Inc Endothelin Antagonists Therapeutics Major Product Offerings
7.1.4 Gilead Sciences, Inc Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.1.5 Gilead Sciences, Inc Key News & Latest Developments
7.2 Sun Pharmaceutical Industries Ltd
7.2.1 Sun Pharmaceutical Industries Ltd Company Summary
7.2.2 Sun Pharmaceutical Industries Ltd Business Overview
7.2.3 Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Major Product Offerings
7.2.4 Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.2.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.3 Lupin
7.3.1 Lupin Company Summary
7.3.2 Lupin Business Overview
7.3.3 Lupin Endothelin Antagonists Therapeutics Major Product Offerings
7.3.4 Lupin Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.3.5 Lupin Key News & Latest Developments
7.4 Zydus Group
7.4.1 Zydus Group Company Summary
7.4.2 Zydus Group Business Overview
7.4.3 Zydus Group Endothelin Antagonists Therapeutics Major Product Offerings
7.4.4 Zydus Group Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.4.5 Zydus Group Key News & Latest Developments
7.5 Endo International plc
7.5.1 Endo International plc Company Summary
7.5.2 Endo International plc Business Overview
7.5.3 Endo International plc Endothelin Antagonists Therapeutics Major Product Offerings
7.5.4 Endo International plc Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.5.5 Endo International plc Key News & Latest Developments
7.6 Mylan NV
7.6.1 Mylan NV Company Summary
7.6.2 Mylan NV Business Overview
7.6.3 Mylan NV Endothelin Antagonists Therapeutics Major Product Offerings
7.6.4 Mylan NV Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.6.5 Mylan NV Key News & Latest Developments
7.7 Teva Pharmaceutical Industries Ltd
7.7.1 Teva Pharmaceutical Industries Ltd Company Summary
7.7.2 Teva Pharmaceutical Industries Ltd Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Major Product Offerings
7.7.4 Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.7.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.8 Sigmapharm Laboratories , LLC
7.8.1 Sigmapharm Laboratories , LLC Company Summary
7.8.2 Sigmapharm Laboratories , LLC Business Overview
7.8.3 Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Major Product Offerings
7.8.4 Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.8.5 Sigmapharm Laboratories , LLC Key News & Latest Developments
7.9 Alembic Pharmaceuticals Limited
7.9.1 Alembic Pharmaceuticals Limited Company Summary
7.9.2 Alembic Pharmaceuticals Limited Business Overview
7.9.3 Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Major Product Offerings
7.9.4 Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.9.5 Alembic Pharmaceuticals Limited Key News & Latest Developments
7.10 Hikma Pharmaceuticals PLC
7.10.1 Hikma Pharmaceuticals PLC Company Summary
7.10.2 Hikma Pharmaceuticals PLC Business Overview
7.10.3 Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Major Product Offerings
7.10.4 Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.10.5 Hikma Pharmaceuticals PLC Key News & Latest Developments
7.11 Amneal Pharmaceuticals LLC
7.11.1 Amneal Pharmaceuticals LLC Company Summary
7.11.2 Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Business Overview
7.11.3 Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Major Product Offerings
7.11.4 Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.11.5 Amneal Pharmaceuticals LLC Key News & Latest Developments
7.12 AstraZeneca
7.12.1 AstraZeneca Company Summary
7.12.2 AstraZeneca Endothelin Antagonists Therapeutics Business Overview
7.12.3 AstraZeneca Endothelin Antagonists Therapeutics Major Product Offerings
7.12.4 AstraZeneca Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.12.5 AstraZeneca Key News & Latest Developments
7.13 Johnsons & Johnsons Private limited
7.13.1 Johnsons & Johnsons Private limited Company Summary
7.13.2 Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Business Overview
7.13.3 Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Major Product Offerings
7.13.4 Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.13.5 Johnsons & Johnsons Private limited Key News & Latest Developments
7.14 GSK Plc
7.14.1 GSK Plc Company Summary
7.14.2 GSK Plc Business Overview
7.14.3 GSK Plc Endothelin Antagonists Therapeutics Major Product Offerings
7.14.4 GSK Plc Endothelin Antagonists Therapeutics Sales and Revenue in Global (2019-2024)
7.14.5 GSK Plc Key News & Latest Developments
8 Global Endothelin Antagonists Therapeutics Production Capacity, Analysis
8.1 Global Endothelin Antagonists Therapeutics Production Capacity, 2019-2030
8.2 Endothelin Antagonists Therapeutics Production Capacity of Key Manufacturers in Global Market
8.3 Global Endothelin Antagonists Therapeutics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Endothelin Antagonists Therapeutics Supply Chain Analysis
10.1 Endothelin Antagonists Therapeutics Industry Value Chain
10.2 Endothelin Antagonists Therapeutics Upstream Market
10.3 Endothelin Antagonists Therapeutics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Endothelin Antagonists Therapeutics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Endothelin Antagonists Therapeutics in Global Market
Table 2. Top Endothelin Antagonists Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Endothelin Antagonists Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Endothelin Antagonists Therapeutics Revenue Share by Companies, 2019-2024
Table 5. Global Endothelin Antagonists Therapeutics Sales by Companies, (K Units), 2019-2024
Table 6. Global Endothelin Antagonists Therapeutics Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Endothelin Antagonists Therapeutics Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Endothelin Antagonists Therapeutics Product Type
Table 9. List of Global Tier 1 Endothelin Antagonists Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Endothelin Antagonists Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Endothelin Antagonists Therapeutics Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Endothelin Antagonists Therapeutics Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Endothelin Antagonists Therapeutics Sales (K Units), 2019-2024
Table 15. By Type - Global Endothelin Antagonists Therapeutics Sales (K Units), 2025-2030
Table 16. By Application ? Global Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Endothelin Antagonists Therapeutics Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Endothelin Antagonists Therapeutics Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Endothelin Antagonists Therapeutics Sales (K Units), 2019-2024
Table 20. By Application - Global Endothelin Antagonists Therapeutics Sales (K Units), 2025-2030
Table 21. By Region ? Global Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Endothelin Antagonists Therapeutics Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Endothelin Antagonists Therapeutics Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Endothelin Antagonists Therapeutics Sales (K Units), 2019-2024
Table 25. By Region - Global Endothelin Antagonists Therapeutics Sales (K Units), 2025-2030
Table 26. By Country - North America Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Endothelin Antagonists Therapeutics Sales, (K Units), 2019-2024
Table 29. By Country - North America Endothelin Antagonists Therapeutics Sales, (K Units), 2025-2030
Table 30. By Country - Europe Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Endothelin Antagonists Therapeutics Sales, (K Units), 2019-2024
Table 33. By Country - Europe Endothelin Antagonists Therapeutics Sales, (K Units), 2025-2030
Table 34. By Region - Asia Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Endothelin Antagonists Therapeutics Sales, (K Units), 2019-2024
Table 37. By Region - Asia Endothelin Antagonists Therapeutics Sales, (K Units), 2025-2030
Table 38. By Country - South America Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Endothelin Antagonists Therapeutics Sales, (K Units), 2019-2024
Table 41. By Country - South America Endothelin Antagonists Therapeutics Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Endothelin Antagonists Therapeutics Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Endothelin Antagonists Therapeutics Sales, (K Units), 2025-2030
Table 46. Gilead Sciences, Inc Company Summary
Table 47. Gilead Sciences, Inc Endothelin Antagonists Therapeutics Product Offerings
Table 48. Gilead Sciences, Inc Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Gilead Sciences, Inc Key News & Latest Developments
Table 50. Sun Pharmaceutical Industries Ltd Company Summary
Table 51. Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Product Offerings
Table 52. Sun Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 54. Lupin Company Summary
Table 55. Lupin Endothelin Antagonists Therapeutics Product Offerings
Table 56. Lupin Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Lupin Key News & Latest Developments
Table 58. Zydus Group Company Summary
Table 59. Zydus Group Endothelin Antagonists Therapeutics Product Offerings
Table 60. Zydus Group Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Zydus Group Key News & Latest Developments
Table 62. Endo International plc Company Summary
Table 63. Endo International plc Endothelin Antagonists Therapeutics Product Offerings
Table 64. Endo International plc Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Endo International plc Key News & Latest Developments
Table 66. Mylan NV Company Summary
Table 67. Mylan NV Endothelin Antagonists Therapeutics Product Offerings
Table 68. Mylan NV Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Mylan NV Key News & Latest Developments
Table 70. Teva Pharmaceutical Industries Ltd Company Summary
Table 71. Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Product Offerings
Table 72. Teva Pharmaceutical Industries Ltd Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 74. Sigmapharm Laboratories , LLC Company Summary
Table 75. Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Product Offerings
Table 76. Sigmapharm Laboratories , LLC Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Sigmapharm Laboratories , LLC Key News & Latest Developments
Table 78. Alembic Pharmaceuticals Limited Company Summary
Table 79. Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Product Offerings
Table 80. Alembic Pharmaceuticals Limited Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Alembic Pharmaceuticals Limited Key News & Latest Developments
Table 82. Hikma Pharmaceuticals PLC Company Summary
Table 83. Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Product Offerings
Table 84. Hikma Pharmaceuticals PLC Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Hikma Pharmaceuticals PLC Key News & Latest Developments
Table 86. Amneal Pharmaceuticals LLC Company Summary
Table 87. Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Product Offerings
Table 88. Amneal Pharmaceuticals LLC Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Amneal Pharmaceuticals LLC Key News & Latest Developments
Table 90. AstraZeneca Company Summary
Table 91. AstraZeneca Endothelin Antagonists Therapeutics Product Offerings
Table 92. AstraZeneca Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. AstraZeneca Key News & Latest Developments
Table 94. Johnsons & Johnsons Private limited Company Summary
Table 95. Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Product Offerings
Table 96. Johnsons & Johnsons Private limited Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Johnsons & Johnsons Private limited Key News & Latest Developments
Table 98. GSK Plc Company Summary
Table 99. GSK Plc Endothelin Antagonists Therapeutics Product Offerings
Table 100. GSK Plc Endothelin Antagonists Therapeutics Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. GSK Plc Key News & Latest Developments
Table 102. Endothelin Antagonists Therapeutics Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 103. Global Endothelin Antagonists Therapeutics Capacity Market Share of Key Manufacturers, 2021-2024
Table 104. Global Endothelin Antagonists Therapeutics Production by Region, 2019-2024 (K Units)
Table 105. Global Endothelin Antagonists Therapeutics Production by Region, 2025-2030 (K Units)
Table 106. Endothelin Antagonists Therapeutics Market Opportunities & Trends in Global Market
Table 107. Endothelin Antagonists Therapeutics Market Drivers in Global Market
Table 108. Endothelin Antagonists Therapeutics Market Restraints in Global Market
Table 109. Endothelin Antagonists Therapeutics Raw Materials
Table 110. Endothelin Antagonists Therapeutics Raw Materials Suppliers in Global Market
Table 111. Typical Endothelin Antagonists Therapeutics Downstream
Table 112. Endothelin Antagonists Therapeutics Downstream Clients in Global Market
Table 113. Endothelin Antagonists Therapeutics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Endothelin Antagonists Therapeutics Segment by Type in 2023
Figure 2. Endothelin Antagonists Therapeutics Segment by Application in 2023
Figure 3. Global Endothelin Antagonists Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Endothelin Antagonists Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Endothelin Antagonists Therapeutics Revenue, 2019-2030 (US$, Mn)
Figure 7. Endothelin Antagonists Therapeutics Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Endothelin Antagonists Therapeutics Revenue in 2023
Figure 9. By Type - Global Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
Figure 11. By Type - Global Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
Figure 12. By Type - Global Endothelin Antagonists Therapeutics Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
Figure 15. By Application - Global Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
Figure 16. By Application - Global Endothelin Antagonists Therapeutics Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Endothelin Antagonists Therapeutics Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
Figure 20. By Region - Global Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
Figure 21. By Country - North America Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
Figure 22. By Country - North America Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
Figure 23. US Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
Figure 28. Germany Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 29. France Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
Figure 37. China Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 41. India Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
Figure 43. By Country - South America Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
Figure 44. Brazil Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Endothelin Antagonists Therapeutics Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Endothelin Antagonists Therapeutics Sales Market Share, 2019-2030
Figure 48. Turkey Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Endothelin Antagonists Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 52. Global Endothelin Antagonists Therapeutics Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Endothelin Antagonists Therapeutics by Region, 2023 VS 2030
Figure 54. Endothelin Antagonists Therapeutics Industry Value Chain
Figure 55. Marketing Channels
